Drug intelligence / Profile preview

mouse GM-CSF

Development stage
Preclinical
Lead developer
Calibr
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous, Inhalation, Intratumoral, Intravesical, Intramuscular, Intraperitoneal
01

Overview

Mouse granulocyte-macrophage colony-stimulating factor (mGM-CSF) is the murine ortholog of the human cytokine GM-CSF (encoded by the *Csf2* gene). It functions as a potent hematopoietic growth factor and immune modulator, signaling through the GM-CSF receptor to stimulate the proliferation and differentiation of myeloid lineage cells, including macrophages and dendritic cells. In preclinical research, mGM-CSF is extensively used as a therapeutic candidate or vaccine adjuvant. It has demonstrated neuroprotective effects in models of Parkinson's disease by inducing regulatory T cells (Tregs), enhanced anti-tumor immunity in bladder cancer and melanoma models (often via oncolytic viral delivery), and improved lung resistance in bacterial pneumonia models. Specific long-acting variants like mPDM608 have been engineered to overcome the short half-life of the recombinant protein for chronic therapeutic applications.

Other names
mouse granulocyte-macrophage colony-stimulating factorCSF2CSF-2CSF 2colony stimulating factor 2
02

Targets

CSF2R (Granulocyte-macrophage colony-stimulating factor receptor)

Beyond the preview

Go deeper on mouse GM-CSF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mouse GM-CSF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call